Safety of thimerosal in vaccines: For whom and how many doses?

Therapie

Volumn 66, Issue 2, 2011, Pages 95-96

  Dórea, José G ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Ethylmercury; Fetus; Methylmercury; Neonates; Neurodevelopment; Pregnancy; Thimerosal; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; TETANUS TOXOID; THIOMERSAL; VACCINE;

ADJUVANT THERAPY; ARTICLE; BRAIN DISEASE; BRAIN INJURY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNIZATION; MENINGOENCEPHALITIS; MERCURIALISM; NEURITIS; NEUROLOGIC DISEASE; NEUROTOXICITY; PERIPHERAL NEURITIS; POLYNEUROPATHY; PREGNANCY; PRIORITY JOURNAL; VACCINATION;

EID: 79959360738     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2011027     Document Type: Article

References (9)

1. Montana M, Verhaeghe P, Ducros C, et al. Safety review: squalene and thimerosal in vaccines. Therapie 2010; 65: 533-41
2. Dórea JG. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines. Clin Chim Acta 2010; 411: 1580-6
3. Dórea JG. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res 2011; in press 2011 Feb 25 [Epub ahead of print]
4. Gallagher C, Goodman M. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Toxicol Environ Chem 2008; 90: 997-1008. http://www.ncims.com/articles/ ThirmerosalandDevelopmentalDisability.pdf
5. Marques RC, Dórea JG, Bernardi JV, et al. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years. Cogn Behav Neurol 2009; 22: 134-41
6. Marques RC, Dórea JG, Bernardi JV. Thimerosal exposure (from tetanusdiphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months. Acta Paediatr 2010; 99: 934-9
7. Lindemayr H, Becerano S. Interaction of mercury compounds and aluminium. Contact Dermatitis 1985; 13: 274 (Pubitemid 16217417)
8. Thyssen JP, Linneberg A, Menne T, et al. The epidemiology of contact allergy in the general population - prevalence and main findings. Contact Dermatitis 2007; 57: 287-99 (Pubitemid 47568789)
9. Czarnobilska E, Obtulowicz K, Dyga W, et al. The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series. Pediatr Allergy Immunol 2011; 22: 252-6